Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Gudme Raaschou - Emerging Markets Debt Fund Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr.74.32 |
52 Week High | kr.74.44 |
52 Week Low | kr.68.94 |
Beta | 0 |
1 Month Change | -0.16% |
3 Month Change | n/a |
1 Year Change | 3.80% |
3 Year Change | n/a |
5 Year Change | -14.22% |
Change since IPO | -26.01% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
GRIEMD | DK Capital Markets | DK Market | |
---|---|---|---|
7D | 0% | -1.3% | 0.3% |
1Y | 3.8% | 16.4% | 26.9% |
Return vs Industry: GRIEMD underperformed the Danish Capital Markets industry which returned 16.4% over the past year.
Return vs Market: GRIEMD underperformed the Danish Market which returned 26.9% over the past year.
Price Volatility
GRIEMD volatility | |
---|---|
GRIEMD Average Weekly Movement | n/a |
Capital Markets Industry Average Movement | 4.3% |
Market Average Movement | 4.6% |
10% most volatile stocks in DK Market | 9.6% |
10% least volatile stocks in DK Market | 2.9% |
Stable Share Price: GRIEMD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GRIEMD's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | n/a |
Gudme Raaschou - Emerging Markets Debt Fund Fundamentals Summary
GRIEMD fundamental statistics | |
---|---|
Market cap | n/a |
Earnings (TTM) | kr.0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs GRIEMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GRIEMD income statement (TTM) | |
---|---|
Revenue | kr.0 |
Cost of Revenue | kr.0 |
Gross Profit | kr.0 |
Other Expenses | kr.0 |
Earnings | kr.0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did GRIEMD perform over the long term?
See historical performance and comparison